null

SMILES: C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1

InChI Key: InChIKey=FCPALNDUDOQUGN-CLOONOSVSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50027811   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50027811 (CHEMBL422876) Show SMILES C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 Show InChI InChI=1S/C26H30ClN3O4S/c1-19(28-18-25(31)22-8-5-9-23(27)16-22)17-29-24-12-10-20(11-13-24)14-15-35(33,34)30-26(32)21-6-3-2-4-7-21/h2-13,16,19,25,28-29,31H,14-15,17-18H2,1H3,(H,30,32)/t19-,25+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	n/a	10	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Ability to cause cAMP accumulation in CHO cells expressing human beta-3 AR expressed as the negative logarithm of the molar drug concentration				J Med Chem 45: 567-83 (2002) BindingDB Entry DOI: 10.7270/Q2W0976P
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50027811 (CHEMBL422876) Show SMILES C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 Show InChI InChI=1S/C26H30ClN3O4S/c1-19(28-18-25(31)22-8-5-9-23(27)16-22)17-29-24-12-10-20(11-13-24)14-15-35(33,34)30-26(32)21-6-3-2-4-7-21/h2-13,16,19,25,28-29,31H,14-15,17-18H2,1H3,(H,30,32)/t19-,25+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	n/a	794	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.				J Med Chem 45: 567-83 (2002) BindingDB Entry DOI: 10.7270/Q2W0976P
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50027811 (CHEMBL422876) Show SMILES C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 Show InChI InChI=1S/C26H30ClN3O4S/c1-19(28-18-25(31)22-8-5-9-23(27)16-22)17-29-24-12-10-20(11-13-24)14-15-35(33,34)30-26(32)21-6-3-2-4-7-21/h2-13,16,19,25,28-29,31H,14-15,17-18H2,1H3,(H,30,32)/t19-,25+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	n/a	316	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Concentration that causes 50% inhibition of human beta 2 adrenergic receptor (AR), expressed in CHO cells.				J Med Chem 45: 567-83 (2002) BindingDB Entry DOI: 10.7270/Q2W0976P
					More data for this Ligand-Target Pair